⌘K
Loading ticker…
Pfizer Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Pfizer Inc. (PFE) has a 3-month relative strength percentile of 24 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 47. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.0%, relative volume 1.33×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
24 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
PFE is in a stage 3 topping pattern, week 2. Currently in a 59-day base; basing ADR 1.9% (broad 2.2%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: -6.5% / -6.1%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
PFE is held by 17 ETFs as of Mar 2026. Top owner: VTI at 0.25% weight, $5.1B notional. Top 3 carry $11.2B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.25% | $5.1B |
| VOOVanguard S&P 500 ETF | 0.29% | $4.1B |
| IVViShares Core S&P 500 ETF | 0.28% | $2.1B |
| SPYState Street SPDR S&P 500 ETF | 0.29% | $1.9B |
| VTVVanguard Value ETF | 0.65% | $1.5B |
| XLVState Street Health Care Select Sector SPDR ETF | 3.01% | $1.2B |
| IWDiShares Russell 1000 Value ETF | 0.52% | $366M |
| SPYMState Street SPDR Portfolio S&P 500 ETF | 0.29% | $336M |
| IVEiShares S&P 500 Value ETF | 0.59% | $275M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.25% | $201M |
Showing 10 of 17 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PFE Jan avg: -3.40% median: -2.99% win: 25% σ: 8.53% n: 4 2022-04-12 → 2026-05-29 | PFE Feb avg: -1.45% median: -1.13% win: 25% σ: 5.24% n: 4 2022-04-12 → 2026-05-29 | PFE Mar avg: 0.62% median: 1.06% win: 75% σ: 3.57% n: 4 2022-04-12 → 2026-05-29 | PFE Apr avg: -5.99% median: -4.92% win: 0% σ: 2.25% n: 5 2022-04-12 → 2026-05-29 | PFE May avg: 2.40% median: -1.95% win: 40% σ: 7.08% n: 5 2022-04-12 → 2026-05-29 | PFE Jun avg: -0.96% median: -1.76% win: 25% σ: 2.94% n: 4 2022-04-12 → 2026-05-29 (current) | PFE Jul avg: -0.03% median: -2.68% win: 25% σ: 6.20% n: 4 2022-04-12 → 2026-05-29 | PFE Aug avg: -2.76% median: -3.45% win: 25% σ: 7.01% n: 4 2022-04-12 → 2026-05-29 | PFE Sep avg: -1.71% median: -1.75% win: 25% σ: 3.93% n: 4 2022-04-12 → 2026-05-29 | PFE Oct avg: -1.74% median: -2.73% win: 25% σ: 5.94% n: 4 2022-04-12 → 2026-05-29 | PFE Nov avg: 1.11% median: 2.06% win: 50% σ: 6.54% n: 4 2022-04-12 → 2026-05-29 | PFE Dec avg: -1.33% median: -1.02% win: 50% σ: 3.67% n: 4 2022-04-12 → 2026-05-29 |